-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$54.40164.33% Upside
Bicycle Therapeutics plc Frequently Asked Questions
-
What analysts cover Bicycle Therapeutics plc?
Bicycle Therapeutics plc has been rated by research analysts at Oppenheimer, B.Riley Financial, H.C. Wainwright, Piper Sandler, Roth Capital in the past 90 days.